Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire<sup>TM</sup> II platform.

Qu, Yusheng; Feric, Nicole; Pallotta, Isabella; Singh, Rishabh; Sobbi, Rooz; Vargas, Hugo M

Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire^TM II platform.

Qu, Yusheng; Feric, Nicole; Pallotta, Isabella; Singh, Rishabh; Sobbi, Rooz; Vargas, Hugo M.

Affiliation

Qu Y; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA. Electronic address: yqu@amgen.com.
Feric N; TARA Biosystems, New York, NY, USA.
Pallotta I; TARA Biosystems, New York, NY, USA.
Singh R; TARA Biosystems, New York, NY, USA.
Sobbi R; TARA Biosystems, New York, NY, USA.
Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA.

J Pharmacol Toxicol Methods ; 105: 106886, 2020 Sep.

Article de En | MEDLINE | ID: mdl-32629159

Sujet(s)
Mots clés

3D; Cardiac contractility; Engineered cardiac tissue; Inotropes; hiPSC-CM

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Régénération / Myocytes cardiaques / Structures d'échafaudage tissulaires / Cellules souches pluripotentes induites Limites: Humans Langue: En Journal: J Pharmacol Toxicol Methods Sujet du journal: FARMACOLOGIA / TOXICOLOGIA Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google